Introduction {#Sec1}
============

Frozen shoulder (FS) or adhesive capsulitis is one of the most common orthopedic conditions affecting the shoulder, with prevalence of 2--5% in the general population \[[@CR1]--[@CR3]\]. This condition commonly occurs between 40 and 60 years of life, with the peak age in the mid-50s \[[@CR4]\]. Although FS was generally thought to resolve in 2--3 years, a recent study indicated that pain and limitation of movement could persist for much longer than these periods \[[@CR4]\]. FS is classically described as a benign condition consisting of three stages: painful freezing, adhesive or frozen, and the thawing or recovery phase. Many patients experienced persistent pain accompanied with limited range of motion (ROM) \[[@CR1], [@CR4]\].

However, the treatment of FS remains controversial despite the many previous studies \[[@CR5], [@CR6]\]. Although conservative treatments, such as nonsteroidal anti-inflammatory drugs (NSAIDs) \[[@CR4]--[@CR8]\], \[[@CR9], [@CR20], [@CR21]\], intra-articular corticosteroid injection \[[@CR4]--[@CR6], [@CR9]--[@CR11]\], physical therapy \[[@CR4]--[@CR6], [@CR12]--[@CR14]\], watchful neglect \[[@CR15]\], and hydrodilatation \[[@CR16]--[@CR18]\], are generally preferred, manipulation under anesthesia \[[@CR4], [@CR19]--[@CR23]\] or surgical treatments such as arthroscopic capsular release \[[@CR24]--[@CR27]\] can be performed in cases of persistent pain and long-term limited ROM.

Manipulation under ultrasound-guided fifth and sixth cervical nerve root block (MUC) is a recognized form of treatment for patients with persistent FS. Minagawa reported the efficacy of shoulder manipulation following the MUC as an outpatient procedure in Japan \[[@CR28]\]. Since MUC facilitates avoidance of blood vessels near the target nerves through visualization \[[@CR29]--[@CR31]\], this procedure has been established as a safe and effective way to ameliorate pain and ROM in patients with persistent FS \[[@CR32], [@CR33]\]. Saito et al. have recently reported that the MUC for FS refractory to conservative treatments resulted in good clinical outcomes for at least 1-year follow-up. However, the study recruited a small number of patients with FS \[[@CR33]\], and several complications have to be considered in a large sample. Thus, a confirmatory study using a large sample should be conducted to validate the efficacy and safety of the MUC procedure.

Therefore, this study aimed to investigate the confirmatory hypothesis testing that the MUC procedure has a significant clinical effect on FS refractory to conservative treatments and to assess its adverse events.

Methods {#Sec2}
=======

Study Participants {#Sec3}
------------------

The sample size was estimated based on a hypothesis that a small-to-medium effect size (Cohen's *d *= 0.4) \[[@CR34]\] could be expected to improve the Japanese Orthopaedic Association (JOA) shoulder score at 6-month follow-up after the MUC procedure. Based on this assumption, the sample size for a power of \> 0.90 with a two-tailed alpha at a significance level of \< 0.05 to run a *t* test (matched pair) required a minimum of 68 patients \[[@CR35]\].

Patients (1) who were diagnosed with FS refractory to conservative treatments such as oral NSAIDs, intra-articular corticosteroid injection, and physical therapy for at least 6 months, (2) who had limited shoulder ROM in at least two directions, i.e., forward flexion of ≤ 100° and external rotation at the side of ≤ 10° \[[@CR33]\], and (3) who were followed up for at least 6 months after the MUC procedure were included in this study.

On the contrary, patients with rotator cuff tear, shoulder osteoarthritis, calcified tendinitis, long head of biceps tendon injury, hemiplegia after stroke, bone metastasis in the shoulder region, history of shoulder fractures, or history of shoulder surgeries were excluded.

Although 77 patients were eligible for this study and all of them underwent the MUC procedure, some could not be followed up until 6 months later. Thus, only 68 patients were finally enrolled (Table [1](#Tab1){ref-type="table"}).Table 1Patient's demographics at baselineVariablesAge (years)52.0 \[38--72\] (7.5)Gender Male/female (%)26 \[38.2%\]/42 \[61.8%\]Affected side Dominant/non-dominant (%)25 \[36.8%\]/43 \[63.2%\]Body mass index (kg/m^2^)23 \[17.7--35\]Presence of diabetes (%)15 \[22.1%\]Continuous data are shown as the mean (SD) or the median \[range\]

Manipulation Procedure and Post-MUC Therapy {#Sec4}
-------------------------------------------

All procedures were performed in the same manner (Fig. [1](#Fig1){ref-type="fig"}); however, patients were treated by either one of the two skilled surgeons (Y.I. or Y.K.). The MUC was performed in an outpatient setting. The patient was placed in a supine position; the cervical nerve roots (C5 and C6) between the anterior and middle scalene muscles were identified using an ultrasound guide (SNiBLE, Konica Minolta, Tokyo, Japan), and then 15--20 ml of 1% lidocaine was injected around the C5/C6. Manipulation was started after evaluating immediate procedural complications and confirming the absence of pain around the shoulder joint at passive forward flexion and abduction.Fig. 1Manipulation procedure. **a** External rotation with the arm at the side to complete the tearing of the anterior capsule. **b** Forward flexion to complete the inferior capsule tear. **c** External rotation with the arm at 90° abduction on the scapula plane to complete the anterior and inferior capsule tears. **d** Internal rotation with the arm at 90° abduction on the scapula plane to complete the posterior and inferior capsule tears. **e** Extension and internal rotation until the vertebral height of the patient's dominant thumb to complete the anterior and superior capsules

Manipulation was first performed at external rotation (Fig. [1](#Fig1){ref-type="fig"}a) to complete the tearing of the anterior capsule and then at forward flexion to complete the inferior capsule tear (Fig. [1](#Fig1){ref-type="fig"}b). Next, external rotation with the arm at the side and at 90° abduction on the scapula plane was performed to complete the anterior and inferior capsule tears (Fig. [1](#Fig1){ref-type="fig"}c). Finally, internal rotation with the arm at 90° abduction on the scapula plane to complete the posterior and inferior capsule tear (Fig. [1](#Fig1){ref-type="fig"}d) and at extension until the vertebral height of the patient's dominant thumb to complete the anterior and superior capsule was performed (Fig. [1](#Fig1){ref-type="fig"}e).

After completing the MUC, we checked the patient's vital signs and injected 10 ml 1% lidocaine and 2.5 mg corticosteroid into the glenohumeral joint to prevent postprocedural pain.

The day after the MUC, we performed radiographic assessments to confirm major complications such as pneumothorax and humeral fracture and also checked for neurologic and vascular injuries. If no complications were noted, patients were encouraged to continue the shoulder rehabilitation program such as passive and active ROM exercises for the next 3 months. Patients were also allowed to use analgesic drugs as necessary.

Clinical Assessments {#Sec5}
--------------------

All of the patients were evaluated immediately before the MUC (baseline) and at 1, 3, and 6 months after with the use of the JOA shoulder score, which consisted of the level of shoulder pain, function, ROM, radiographic findings, and joint stability, ranging from 0 to 100 points. Probable maximum scores for each subcategory were 30 points for pain, 20 for function, 30 for ROM, 5 for radiographic findings, and 15 for joint stability, with higher scores indicating better outcome \[[@CR36]\]. We also measured ROMs of the affected shoulder in two directions at the same time: forward flexion and external rotation.

We investigated the following potential variables: age, gender, affected side (dominant or non-dominant), body mass index (BMI), and presence of diabetes, which were possible factors associated with the severity of symptoms in patients with FS. BMI was calculated based on these values using the following formula: BMI = weight (kg)/height (m^2^). The mean period of diabetes was 10 years \[range 5--20\].

Furthermore, we assessed any adverse events during and after the MUC.

Statistical Analysis {#Sec6}
--------------------

Continuous data were presented as the mean and standard deviation (SD) in normal distribution or as median and ranges \[*X* to *Y*\] in non-normal distribution. The Shapiro-Wilk test was used to investigate whether the data were normally distributed. A paired t-test or a Wilcoxon signed-rank test was used to compare differences in each outcome between the baseline and 6 months after the procedure as appropriate. Although the statistical significance was set as *p* \< 0.05, *p* \< 0.017 was considered significant after a Bonferroni correction, because three outcome variables were used to evaluate the efficacy of the MUC.

We also used a repeated measure analysis of variance or a Friedman test to evaluate each outcome at every follow-up point: baseline, 1, 3, and 6 months after the procedure. If these analyses demonstrated a significant chronologic effect, multiple comparison was performed using the Scheffé method, and statistical significance was set as *p* \< 0.05.

Subsequently, we determined five independent variables: age, gender, affected side, BMI, and presence of diabetes, which were possible factors associated with the JOA shoulder score at baseline. A stepwise multiple linear regression was conducted to determine which independent variables best correlated with the recovery rate, and statistical significance was set as *p* \< 0.05. All of these analyses were conducted using IBM SPSS^®^ 25.0 software for Windows^®^ (IBM Inc.).

Study Design and Ethical Approval {#Sec7}
---------------------------------

The study was approved by the ethical committee at Aichi Medical University and performed in accordance with the 1964 Helsinki declaration and its later amendments. Due to the retrospective nature of the study design, written consent form of the study was waived for patients treated during the study period unless they refused to provide the information in accordance with the opt-out strategy.

Results {#Sec8}
=======

Among the patients who underwent the MUC procedure, 11 had dropped out during the 6-month follow-up period. Patient demographics at baseline are shown in Table [1](#Tab1){ref-type="table"}. The mean age of patients was 52.0 years, the number of females was approximately two times that of males, and the dominant limb was involved approximately twice as often as that of the non-dominant limb. In the correlation analysis, we found that the predicted variables were not significantly correlated with the JOA score at baseline (Table [2](#Tab2){ref-type="table"}).Table 2Spearman's correlation coefficients between each variable and the JOA shoulder score at baselineAgeGender (1: male, 2: female)Affected side (1: dominant, 2: non-dominant)BMIDiabetesJOA shoulder score0.078− 0.066− 0.070− 0.107− 0.144*p* value0.530.590.570.380.24

Regarding the primary outcome, the confirmatory testing showed statistically significant improvements in every outcome value at 6 months after the MUC compared with those at baseline (Fig. [2](#Fig2){ref-type="fig"}). The JOA shoulder scores showed a significant improvement from 58.4 (8.1) at baseline to 92.6 (8.2) and 95 \[63--100\] at 6-month follow-up (*p* \< 0.001). The degrees of ROMs in forward flexion and external rotation also showed significant improvement from 90 \[60--90\] and 10 \[5--15\] at baseline to 167.5 \[80--180\] and 42.5 \[0--70\] at 6-month follow-up, respectively (*p* \< 0.001, *p* \< 0.001).Fig. 2Each outcome value at pre-MUC and 6 months after MUC

Time series analysis also indicated that each outcome value displayed a chronologic improvement (Table [3](#Tab3){ref-type="table"}).Table 3Changes in each parameter from baseline to follow-ups over a 6-month periodPre MUCAfter MUC1 month3 months6 monthsJOA shoulder score (point)58.4 (8.1)85.5 \[57--100\]\*89.5 \[60--100\]\*^,§^95 \[63--100\]\*^,§,¶^Degree of forward flexion (°)90 \[60--100\]150 \[70--180\]\*160 \[90--180\]\*^,§^167.5 \[80--100\]\*^,§^Degree of external rotation (°)10 \[5--15\]42.5 \[0--70\]\*50 \[0--70\]\*^,§^52.5 \[0--70\]\*^,§^Continuous data are shown as the mean (SD) or the median \[range\]Symbols indicate significant difference in each value by Scheffé comparison (*p* \< 0.05); \*vs. pre-MUC, ^§^vs. 1 month after MUC, ^¶^vs. 3 months after MUC

In terms of adverse events, two patients (2.9%) had vasovagal reflex and one (1.5%) had a panic attack during the block procedure, resulting in full recovery after several hours without treatment and returned home on the same day. Regarding the complication related to manipulation, a 72-year-old female patient (1.2%) had an avulsion fracture of the inferior glenoid rim during the manipulation that healed spontaneously without any residual functional impairment.

Discussion {#Sec9}
==========

This study hypothesized that the MUC had a significant clinical effect on FS refractory to at least 6-month conservative treatments, and we confirmed that significant chronologic effects of the MUC on FS were observed through a confirmatory analysis with a sufficient sample size. In contrast, the study also considered that several complications could occur during the block and manipulation procedures even if performed by skilled surgeons.

Early recovery from FS is essential to improve an individual's quality of life. Although its pathogenesis has been described as inflammatory thickening of the articular capsule, the development of intra- or extra-articular synovial inflammation \[[@CR37], [@CR38]\], a consistent mechanism of ROM restriction, remains unclear. Although FS was generally thought to resolve in 2--3 years, a recent study indicated that pain and limitation of movement could persist for much longer than these periods \[[@CR4]\]. Aging, female gender, non-dominant shoulder, and increased BMI have been reported to be likely associated with FS \[[@CR4], [@CR39]\]; moreover, diabetes is one of the dominant diseases associated with FS \[[@CR4], [@CR39], [@CR40]\]. However, only 22.1% of the patients had diabetes in this study; therefore, the JOA score was not statistically associated with the presence of diabetes. This result could be caused by sample selection bias, because a trend of mild correlation (*r* = − 0.14) was observed between the two parameters.

The MUC has been suggested and performed with satisfactory results. In addition, the pros and cons of the block method will also be discussed here. Pobiel et al. have reported complications of fluoroscopic-guided interscalene brachial plexus block (ISB) such as hematoma by vascular puncture, pneumothorax, spinal cord insult, and nerve root deficit \[[@CR41]\]. Although uncommon, ISB can result in devastating results \[[@CR42], [@CR43]\]. An ultrasound-guided approach could prevent these complications through continuous visualization of the treatment site through real-time images during the block procedure. This method is also helpful to prevent both physicians and patients from external radiation exposure. However, an ultrasound-guided approach requires precise knowledge on the association between real anatomical structures and ultrasound reflecting structures; thus, long-standing experience is needed.

Although major complications were not observed in our study, two patients had vasovagal reflex and one had a panic attack during the block procedure. Pobiel et al. have reported minor complications that could occur within 30 min of the block procedure \[[@CR41]\]. Although these are nonspecific symptoms and generally do not require specific treatment, vasovagal reactions and sympathetic blockade are prevalent in this block \[[@CR41]\]. Three minor complications (3.9%) were observed in our study, and the rate of incidence was consistent with that of the previous report \[[@CR41]\]. Therefore, physicians should be aware of these minor complications during the block procedure.

Surgeons should also consider the complications of shoulder manipulation. Sasanuma et al. reported that magnetic resonance imaging (MRI) in patients with severe FS after MUC showed capsule tears, labrum tears, and bone bruises in the humeral head, and approximately 50% of patients had bone bruises \[[@CR32]\]. Major complications, such as rotator cuff injury, humeral fracture, shoulder dislocation, and traction nerve injury, seldom occur \[[@CR44], [@CR45]\]. Magnussen described in a case report that a glenoid fracture is associated with manipulation under anesthesia for adhesive capsulitis \[[@CR46]\], and Vastamaki et al. also described two inferior glenoid rim fractures \[[@CR23]\]. In this study, a 72-year-old female patient who was not assessed for bone vulnerability had an avulsion fracture of the inferior glenoid rim after manipulation. This implies that we should assess the degree of osteoporosis prior to the procedure and perform a particularly meticulous procedure in elderly female patients.

Altogether, manipulation under anesthesia for FS is a relatively safe and effective procedure; thus, surgeons who perform it should be aware of and alert patients on potential complications because a capsular release technique always has potential tissue insults.

There are several limitations to our study. First, although this study showed a significant effect of the MUC on FS refractory to at least 6-month conservative treatment, no controls were set. As the patients had suffered from pain and disabilities for at least 6 months, continuing general therapy was difficult. Thus, the degree of superiority of MUC compared with other treatments or the natural course is unknown.

Second, psychologic disorders have been reportedly associated with shoulder pain and restrictions in patients with FS \[[@CR47]\]; however, this study did not include psychologic assessments.

Third, although the clinical stage of FS was not assessed at baseline, this may have affected the results. Fourth, we did not evaluate MRI after MUC; however, several tissue insults could be found such as bone bruises if screening MRI was performed for each case. Lastly, although diabetes was not associated with disease severity at baseline among this sample, other relevant comorbidities such as thyroid disorders and hyperlipidemia should have been assessed as well \[[@CR39], [@CR48]\]. Rigorous studies utilizing appropriate methodologies could clarify the clinical significance of the MUC on FS refractory to conservative treatments.

Conclusion {#Sec10}
==========

This study hypothesized that the MUC had a significant clinical effect on FS refractory to at least 6-month conservative treatment, and we confirmed that significant chronologic effects of the MUC on FS were observed through confirmatory analysis with a sufficient sample size. However, two patients (2.4%) had a vasovagal reflex, one (1.1%) had a panic attack, and one (1.1%) had an avulsion fracture of the inferior glenoid rim. The MUC for FS is a relatively safe and effective procedure; thus, surgeons who perform it should be aware of and alert patients to potential complications because a capsular release technique always has potential tissue insults.
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